Occident | Activity | F4

Team Portfolio Raise Essays

F4/Occident/Activity

Occident Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Participated in Immitra Bio's CHF 2.4M Pre-Seed round for an in-vivo gene therapy platform for rare genetic diseases.

Immitra Bio

Immitra Bio Occident

occident.groupJUL 21, 2026

JUL 21, 2026

Exit

Portfolio company Tubulis entered a definitive acquisition agreement with Gilead.

Tubulis

Tubulis Occident

occident.groupAPR 7, 2026

APR 7, 2026

Investment

Participated in Tubulis' >€300M Series C, led by Venrock Healthcare Capital Partners, to advance antibody-drug conjugate development.

Tubulis

Tubulis Occident

occident.groupOCT 15, 2025

OCT 15, 2025

News

Team strategy retreat in the Austrian Alps to strengthen firm strategy and team cohesion.

OCCIDENT team retreat in the Austrian Alps

occident.groupSEP 11, 2025

SEP 11, 2025

Milestone

Thermosome reported promising Phase 1 efficacy and safety data for THE001, supporting progression to Phase 2 in advanced soft-tissue sarcoma.

Thermosome

Thermosome Occident

occident.groupJUN 24, 2025

JUN 24, 2025

Milestone

ReCatalyst established a strong advisory board of four international industry experts ahead of its next growth phase.

ReCatalyst

ReCatalyst Occident

occident.groupJUN 4, 2025

JUN 4, 2025

News

Hosted the fifth OCCIDENT Pitch Event in Munich, featuring 18 startups nominated by OCCIDENT, the Helmholtz Association, and xista science ventures.

OCCIDENT Pitch Event, 5th edition, Munich

occident.groupMAR 26, 2025

MAR 26, 2025

Milestone

Algiax presented promising Phase 2 results for lead compound AP-325 in peripheral postoperative neuropathic pain, showing reduced side effects.

Algiax Pharmaceuticals

Algiax Pharmaceuticals Occident

occident.groupFEB 4, 2025

FEB 4, 2025

Milestone

Tubulis advanced its second drug candidate, TUB-030, a next-generation ADC, into Phase I/IIa clinical evaluation for advanced solid tumors.

Tubulis

Tubulis Occident

occident.groupJAN 30, 2025

JAN 30, 2025

3 exits· JAN 2014 – SEP 2023Show all

Exit

Portfolio company adivo was acquired by animal health company Zoetis.

adivo acquired by Zoetis

occident.groupSEP 15, 2023

SEP 15, 2023

Exit

Portfolio company Cunesoft was successfully exited.

Cunesoft exit

occident.groupJAN 15, 2020

JAN 15, 2020

Exit

Portfolio company Kooaba, an image-recognition startup, was acquired by Qualcomm.

Kooaba acquired by Qualcomm

startupticker.chJAN 2014

JAN 2014